Dr. Richard Drake’s research in proteomics focuses on identifying specific protein biomarkers associated with different types and stages of cancers, as well as developing protein biomarker tests that could monitor the effectiveness of treatment. Ultimately, the Proteomics Center of Economic Excellence hopes to translate the research of Dr. Drake and his team into commercialized biomarker tests for a variety of medical fields.
Dr. Drake is among the nation’s leading experts on the complex role of proteins in the development of cancer. In addition to his SmartState Endowed Chair appointment, he is a professor in the MUSC Department of Cell and Molecular Pharmacology and Experimental Therapeutics, and is working with scientists at MUSC’s Hollings Cancer Center.
Dr. Drake has significant funding from the National Institutes of Health and Department of Defense for prostate and kidney cancer research. His research could result in commercialized biomarker tests for a variety of medical fields, including new diagnostic tests that define how well cancer treatments are working.